News and analysis on diagnostic technologies and applications.
The firm said it is drawing up plans for its business in a post-pandemic world, planning the introduction of new testing panels and enhancing its respiratory panel.
During a conference call, company executives also discussed results from the SMART NIPT trial and their outlook for Natera's three businesses.
Labs like Biodesix, ARUP, Quest, and Labcorp engaged different strategies to prevent loss of patient samples during recent extreme weather.
The rapid, chromatographic immunoassay qualitatively detects the nucleocapsid protein of SARS-CoV-2 from nasal swabs and is CE marked.
The firm, in its development work, has multiplexed up to 57 different analytes, obtaining quantitative results using one cartridge and one patient sample, its CEO said.
